Neuroblastoma

Oncology·MeSH: Neuroblastoma

Prevalence

30.0 / 100K

89 drugs in development·16 companies·25 clinical trials

Drug Pipeline by Phase

Approved(4)

Drug	Company
cyclophosphamide	NEXUS BIOPHARMA INC (NEXS)
danyelza	Y-mAbs Therapeutics, Inc. (YMAB)
doxorubicin	Amneal Pharmaceuticals, Inc. (AMRX)
Unituxin	UNITED THERAPEUTICS Corp (UTHR)

Phase 3(22)

Drug	Company
Ceritinib	ENANTA PHARMACEUTICALS INC (ENTA)
Dasatinib	Filana Therapeutics Inc. (FLNA)
Dinituximab	Black Diamond Therapeutics, Inc. (BDTX)
Dinutuximab	Black Diamond Therapeutics, Inc. (BDTX)
Dinutuximab	ENANTA PHARMACEUTICALS INC (ENTA)
Dinutuximab	PTC THERAPEUTICS, INC. (PTCT)
Dinutuximab with Chemotherapy	UNITED THERAPEUTICS Corp (UTHR)
Eflornithine Hydrochloride	Filana Therapeutics Inc. (FLNA)
etoposide	Black Diamond Therapeutics, Inc. (BDTX)
Etoposide	PTC THERAPEUTICS, INC. (PTCT)
Etoposide phosphate	Black Diamond Therapeutics, Inc. (BDTX)
Isotretinoin	Filana Therapeutics Inc. (FLNA)
Isotretinoin	PTC THERAPEUTICS, INC. (PTCT)
Isotretinoin	Black Diamond Therapeutics, Inc. (BDTX)
Isotretinoin	ENANTA PHARMACEUTICALS INC (ENTA)
Melphalan	PTC THERAPEUTICS, INC. (PTCT)
Melphalan	Black Diamond Therapeutics, Inc. (BDTX)
temozolomide	Black Diamond Therapeutics, Inc. (BDTX)
Thiotepa	PTC THERAPEUTICS, INC. (PTCT)
Thiotepa	Black Diamond Therapeutics, Inc. (BDTX)
Topotecan	Black Diamond Therapeutics, Inc. (BDTX)
Vincristine	Black Diamond Therapeutics, Inc. (BDTX)

Phase 2(48)

Drug	Company
Ceritinib	Filana Therapeutics Inc. (FLNA)
Cytoxan	Filana Therapeutics Inc. (FLNA)
Cytoxan	Merus N.V. (MRUS)
Cytoxan	ENANTA PHARMACEUTICALS INC (ENTA)
Cytoxan	PTC THERAPEUTICS, INC. (PTCT)
DANYELZA	Filana Therapeutics Inc. (FLNA)
DANYELZA	ENANTA PHARMACEUTICALS INC (ENTA)
DANYELZA	Merus N.V. (MRUS)
DANYELZA	PTC THERAPEUTICS, INC. (PTCT)
DFMO	ENANTA PHARMACEUTICALS INC (ENTA)
DFMO	Filana Therapeutics Inc. (FLNA)
Dinutuximab	Merus N.V. (MRUS)
Dinutuximab	UNITED THERAPEUTICS Corp (UTHR)
Eflornithine Hydrochloride	PTC THERAPEUTICS, INC. (PTCT)
Eflornithine Hydrochloride	Black Diamond Therapeutics, Inc. (BDTX)
GM-CSF	UNITED THERAPEUTICS Corp (UTHR)
gm-csf + naxitamab	Y-mAbs Therapeutics, Inc. (YMAB)
GM-CSF + Naxitamab	Filana Therapeutics Inc. (FLNA)
hu14.18k322a	GH Research PLC (GHRS)
hu14.18K322A	PTC THERAPEUTICS, INC. (PTCT)
hu14.18K322A	Black Diamond Therapeutics, Inc. (BDTX)
hu14.18K322A	CG Oncology, Inc. (CGON)
hu14.18K322A	Filana Therapeutics Inc. (FLNA)
Ifosfamide	ENANTA PHARMACEUTICALS INC (ENTA)
Ifosfamide	Filana Therapeutics Inc. (FLNA)
n803	GH Research PLC (GHRS)
N803	CG Oncology, Inc. (CGON)
N803	Filana Therapeutics Inc. (FLNA)
N803	Black Diamond Therapeutics, Inc. (BDTX)
N803	PTC THERAPEUTICS, INC. (PTCT)
Neoadjuvant Chemotherapy	UNITED THERAPEUTICS Corp (UTHR)
OPT-821	Crinetics Pharmaceuticals, Inc. (CRNX)
Radiation	UNITED THERAPEUTICS Corp (UTHR)
sargramostim	GH Research PLC (GHRS)
Sargramostim	Merus N.V. (MRUS)
Sargramostim	CG Oncology, Inc. (CGON)
Sargramostim	UNITED THERAPEUTICS Corp (UTHR)
Sargramostim	ENANTA PHARMACEUTICALS INC (ENTA)
Sargramostim	Black Diamond Therapeutics, Inc. (BDTX)
Sargramostim	Filana Therapeutics Inc. (FLNA)
Sargramostim	PTC THERAPEUTICS, INC. (PTCT)
Temozolomide	Filana Therapeutics Inc. (FLNA)
Topotecan	PTC THERAPEUTICS, INC. (PTCT)
Topotecan	Filana Therapeutics Inc. (FLNA)
Topotecan	ENANTA PHARMACEUTICALS INC (ENTA)
vorinostat	ENANTA PHARMACEUTICALS INC (ENTA)
Vorinostat	UNITED THERAPEUTICS Corp (UTHR)
Vorinostat	Filana Therapeutics Inc. (FLNA)

Phase 1(10)

Drug	Company
AUTO6NG	Autolus Therapeutics plc (AUTL)
Dinituximab	PTC THERAPEUTICS, INC. (PTCT)
Fludarabine	UNITED THERAPEUTICS Corp (UTHR)
kur-501	Athenex, Inc. (ATNX)
ly3295668 erbumine	ELI LILLY & Co (LLY)
Potassium Iodide	UNITED THERAPEUTICS Corp (UTHR)
rhIL-15	PTC THERAPEUTICS, INC. (PTCT)
rhIL-15	Black Diamond Therapeutics, Inc. (BDTX)
Thiotepa	ENANTA PHARMACEUTICALS INC (ENTA)
Topotecan	ELI LILLY & Co (LLY)

Unknown(2)

Drug	Company
eflornithine HCl	Filana Therapeutics Inc. (FLNA)
eflornithine HCl	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 1/Phase 2(1)

Drug	Company
elraglusib	ACTUATE THERAPEUTICS, INC. (ACTU)

Phase 4(2)

Drug	Company
Dinituximab	Filana Therapeutics Inc. (FLNA)
Dinutuximab	Filana Therapeutics Inc. (FLNA)

Compare drugs

cyclophosphamide vs danyelza cyclophosphamide vs doxorubicin cyclophosphamide vs Unituxin

Frequently asked questions

How many drugs are in development for Neuroblastoma?

BioSniper tracks 89 drugs in development for Neuroblastoma across 16 companies.

How many clinical trials target Neuroblastoma?

There are 25 clinical trials targeting Neuroblastoma tracked by BioSniper.

What is the prevalence of Neuroblastoma?

The estimated prevalence of Neuroblastoma is approximately 30.0 per 100,000 population.

Deep-dive into Neuroblastoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis